In August 2025, a rare case study jointly conducted by Baoding Central Blood Station and several hospitals was published, reporting a 7-year-old boy with McLeod syndrome caused by XK gene deletion
2025-09-24
Wang Hao, CEO of Jiangsu Weihe Biotechnology Co., Ltd., as the secretary of the Party branch, organized all employees to watch the military parade ceremony in the companys lecture hall.
2025-09-03
On August 25, 2025, in Suzhou, Jiangsu, Weihe Biotech, a pioneer in Chinas transplantation, blood transfusion, and immunogenetic molecular diagnosis fields, collaborated with MGI, a creator of core to
2025-08-28
Weihe Biotech sincerely invites you to attend the Oriental Blood Transfusion Conference
2025-08-05
Recently, the overseas team of Weihe Biotech has been busy, traveling to Kuala Lumpur, Malaysia, to conduct in-depth visits to key customers in the fields of transplantation and blood transfusion
2025-07-21
The 2025 Guangdong Province Clinical Blood Transfusion Advanced Training Course has successfully concluded at Guangzhou Medical University, and Weihe Biotechnology is honored to participate and provid
2025-06-30
On the occasion of World Blood Donation Day in 2025, Weihe Biotechnology wishes every blood donor well. At the same time, it also contributes to the blood transfusion industry through continuous techn
2025-06-14
When Bibo in Xin anjiang meets the pride of Mount Huangshan Pine, and when the Anhui style ancient charm collision team is enthusiastic, the 2025 group building activity of Jiangsu Weihe Biotechnology
2025-04-22
Any genetic polymorphism that can be detected in the blood can be referred to as blood type, but blood type is usually limited to the polymorphism of blood cell surface antigens, including red blood c
2025-04-02
The 22nd China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo (CACLP) and the 5th China International IVD Upstream Raw Materials and Supply Chain Expo (CISCE) will be
2025-03-19
Now Location：Home--News Center--Company News
